Advertisement

Topics

Alfa Wassermann Company Profile

07:44 EDT 25th September 2017 | BioPortfolio

Nil

Contact

Phone: 39.085.8571226
Fax: 39.085.8543128
Email: ordini@alfawassermanndiagnostics.it


News Articles [94 Associated News Articles listed on BioPortfolio]

Alfa Wassermann SpA Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAlfa Wassermann SpA Alfa Wassermann, a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in med...

Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 11, Authorised

Protalix Wins FDA Approval as Multi-Product Facility

To support the potential manufacture of pegunigalsidase alfa and taliglucerase alfa on a commercial scale

FDA rejects Pfizer’s epoetin alfa biosimilar

US pharma giant Pfizer announced on 22 June 2017 that the US Food and Drug Administration (FDA) had rejected its application for approval of its epoetin alfa biosimilar.

Driving The Alfa Romeo Giulia QV With A Manual Box

The Giulia Quadrifoglio deserves to be in Race mode all the time, because it's a proper Alfa Romeo, and the sports sedan we've been waiting for.

FDA for first time recommends approval for biosimilar erythropoiesis-stimulating agent

Brian BerkThe committee’s recommendation was based on its review of the totality of evidence, including demonstration of comparable efficacy and safety of Pfizer’s biosimilar epoetin alfa ...

FDA panel recommends approval of Hospira’s Epogen biosimilar

Brian BerkThe committee’s recommendation was based on its review of the totality of evidence, including demonstration of comparable efficacy and safety of Pfizer’s biosimilar epoetin alfa ...

FDA panel recommends Pfizer’s epoetin alfa biosimilar to treat anemia

The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of Pfizer's biosimilar to Amgen’s anemia drug Epogen (epoetin alfa) across all in...

Drugs and Medications [59 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets Initial U.S. Approval: 200...

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribasphere ribapak [Three Rivers Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Ribasphere (ribavirin, USP) safely and effectively. See full prescribing information for Ribasphere (ribavirin, USP). Ribasphere (riba...

PubMed Articles [40 Associated PubMed Articles listed on BioPortfolio]

Asymmetric Synthesis of alfa,alfa-Disubstituted Allylic Amines via Pd-Catalyzed Allylic Substitution.

The first asymmetric synthesis of important alfa,alfa-disubstituted N-alkyl allyl amine scaffolds via allylic substitution is reported. This approach is based on palladium catalysis and features ample...

Patient evaluation of the redesigned follitropin alfa pen injector.

We aimed to evaluate the overall impressions of learning and subsequent use of the redesigned GONAL-f® (follitropin alfa) pen injector by women with recent or current infertility requiring assisted r...

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial.

To compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants.

Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.

Andexanet alfa is a recombinant factor Xa decoy molecule that inhibits direct and indirect factor Xa inhibitors to allow the normal coagulation process to resume. Its development arises in a space whe...

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin alfa (GGF2) Clinical Trials.

Cimaglermin alfa (GGF2) is a recombinant human protein growth factor in development for heart failure. Phase 1 trials were suspended when 2 cimaglermin alfa-treated subjects experienced concomitant el...

Clinical Trials [856 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [25 Associated Companies listed on BioPortfolio]

Alfa Wassermann, Inc

Under one name or another, Alfa Wassermann, Inc. has provided high quality products and services to the health care community since 1960. Our parent company, the Alfa Wassermann Group, headquartered i...

Alfa Wassermann

Nil

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

More Information about "Alfa Wassermann" on BioPortfolio

We have published hundreds of Alfa Wassermann news stories on BioPortfolio along with dozens of Alfa Wassermann Clinical Trials and PubMed Articles about Alfa Wassermann for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Wassermann Companies in our database. You can also find out about relevant Alfa Wassermann Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record